Showing results (431-440 of 7,003) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|July 14, 2006
Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patientsAntonio Santo, Giovenzio Genestreti, Alberto Terzi, et al.Lung Cancer (Amsterdam, Netherlands)|July 14, 2006
C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancerMichael I Koukourakis, Dimitrios Papazoglou, Alexandra Giatromanolaki, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE)Anil Wali, Patrice J Morin, Colleen D Hough, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapyKlaus Junker, Ulf Stachetzki, Daniela Rademacher, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in ChinaXiao-Feng Chen, Hong-Tao Zhang, Qing-Yuan Qi, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancerFrank B Zimmermann, Hans Geinitz, Sabine Schill, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLCM De Lena, R Ramlau, O Hansen, et al.Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancerJun Araki, Isamu Okamoto, Ryuichiro Suto, et al.Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in ItalyS Novello, A Kielhorn, G Stynes, et al.Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and NorwayHalla Skuladottir, Herman Autrup, Judith Autrup, et al.Pageof 701